🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Bayer offers to sell businesses to win EU approval for Monsanto deal

Published 05/02/2018, 18:18
Updated 05/02/2018, 18:20
© Reuters. FILE PHOTO - The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal
BAYGN
-
MON
-

By Foo Yun Chee and Ludwig Burger

BRUSSELS/FRANKFURT (Reuters) - Bayer (DE:BAYGN) has offered to sell seeds and pesticides businesses to try to address EU competition concerns over its $63.5 billion (£45.3 billion) bid for U.S. rival Monsanto (NYSE:MON).

The proposed remedies "are very significant and we are confident they fully address the European Commission's concerns," the German company said in a statement on Monday.

The European Commission extended the deadline for its decision on the deal to April 5 from March 12.

Bayer said it was still aiming to wrap up the deal "in early 2018." Both the EU competition enforcer and Bayer declined to say what assets Bayer had offered to put on the block.

The offer includes assets to be sold to BASF as well divestments of vegetable seeds business in some EU countries, a person familiar with the matter said.

"This is a very diverse package. It is not just about divesting assets," the person said, declining to provide details.

Depending on the feedback from third parties, it is possible the package could be adjusted, the source said. The Commission is expected to seek comment from industry rivals and customers in the coming days.

Bayer struck a deal with BASF in October last year to sell seed and herbicide businesses for 5.9 billion euros (£5.2 billion) but has said it is prepared to do more to gain EU approval.

The Monsanto deal has triggered opposition from some farmers and environmentalists who have sent more than 50,000 petition emails and more than 5,000 letters to the Commission.

© Reuters. FILE PHOTO - The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.